Overview

PET/CT Imaging in COVID-19 Patients

Status:
Enrolling by invitation

Trial end date:
2022-05-01

Target enrollment:

Participant gender:

Summary

This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of California, Davis